293 related articles for article (PubMed ID: 26531104)
21. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581
[TBL] [Abstract][Full Text] [Related]
22. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity and cellular response mechanisms of water-soluble platinum(II) complexes of lidocaine and phenylcyanamide derivatives.
Tabrizi L; Chiniforoshan H
Biometals; 2017 Feb; 30(1):59-70. PubMed ID: 27995355
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of a platinum(II) complex with 2-(4-methoxy-phenyl) imidazo [4,5-f]-[1,10] phenanthrolin and study of its antitumor activity.
Qin QP; Chen ZF; Shen WY; Jiang YH; Cao D; Li YL; Xu QM; Liu YC; Huang KB; Liang H
Eur J Med Chem; 2015 Jan; 89():77-87. PubMed ID: 25462228
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
26. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
Escolà A; Crespo M; López C; Quirante J; Jayaraman A; Polat IH; Badía J; Baldomà L; Cascante M
Bioorg Med Chem; 2016 Nov; 24(22):5804-5815. PubMed ID: 27670096
[TBL] [Abstract][Full Text] [Related]
27. DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.
Brodie CR; Collins JG; Aldrich-Wright JR
Dalton Trans; 2004 Apr; (8):1145-52. PubMed ID: 15252653
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity profile of novel sterically hindered platinum(II) complexes with (1R,2R)-N(1),N(2)-dibutyl-1,2-diaminocyclohexane.
Zhang H; Gou S; Zhao J; Chen F; Xu G; Liu X
Eur J Med Chem; 2015; 96():187-95. PubMed ID: 25874342
[TBL] [Abstract][Full Text] [Related]
29. A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
Shahsavar F; Bozorgmehr M; Mirzadegan E; Abedi A; Lighvan ZM; Mohammadi F; Safari N; Amani V; Zarnani AH
Anticancer Agents Med Chem; 2016; 16(3):393-403. PubMed ID: 26899296
[TBL] [Abstract][Full Text] [Related]
30. A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues.
Margiotta N; Capitelli F; Ostuni R; Natile G
J Inorg Biochem; 2008 Dec; 102(12):2078-86. PubMed ID: 18760482
[TBL] [Abstract][Full Text] [Related]
31. A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin.
Suntharalingam K; Mendoza O; Duarte AA; Mann DJ; Vilar R
Metallomics; 2013 May; 5(5):514-23. PubMed ID: 23487034
[TBL] [Abstract][Full Text] [Related]
32. Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells.
Wang FY; Tang XM; Wang X; Huang KB; Feng HW; Chen ZF; Liu YN; Liang H
Eur J Med Chem; 2018 Jul; 155():639-650. PubMed ID: 29935437
[TBL] [Abstract][Full Text] [Related]
33. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
[TBL] [Abstract][Full Text] [Related]
34. New imidoyl-indazole platinum (II) complexes as potential anticancer agents: Synthesis, evaluation of cytotoxicity, cell death and experimental-theoretical DNA interaction studies.
Cabrera AR; Espinosa-Bustos C; Faúndez M; Meléndez J; Jaque P; Daniliuc CG; Aguirre A; Rojas RS; Salas CO
J Inorg Biochem; 2017 Sep; 174():90-101. PubMed ID: 28648925
[TBL] [Abstract][Full Text] [Related]
35. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
Zhou Z; Chen F; Xu G; Gou S
Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
[TBL] [Abstract][Full Text] [Related]
36. Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway.
Qin QP; Wang SL; Tan MX; Wang ZF; Luo DM; Zou BQ; Liu YC; Yao PF; Liang H
Eur J Med Chem; 2018 Oct; 158():106-122. PubMed ID: 30205260
[TBL] [Abstract][Full Text] [Related]
37. In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N'-di-2-propanoic Acid.
Zmejkovski BB; Pantelić N; Filipović L; Aranđelović S; Radulović S; Sabo TJ; Kaluđerović GN
Anticancer Agents Med Chem; 2017; 17(8):1136-1143. PubMed ID: 27928952
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes.
Savić A; Filipović L; Aranđelović S; Dojčinović B; Radulović S; Sabo TJ; Grgurić-Šipka S
Eur J Med Chem; 2014 Jul; 82():372-84. PubMed ID: 24927057
[TBL] [Abstract][Full Text] [Related]
39. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.
Zhang J; Li L; Ji X; Sun J; Wang L; Zhang Y
Eur J Med Chem; 2010 Jun; 45(6):2634-7. PubMed ID: 20153562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
